|
Krebs Biochemicals & Industries Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
148.03 Cr.
|
P/BV
|
-1.01
|
Book Value (Rs.)
|
-67.83
|
|
52 Week High/Low (Rs.)
|
114/64
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
27/09/2023
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| No. of Equity Shares (in Lacs) | 215.60 | 215.60 | 215.60 | 215.60 | 196.20 |
| | | | | | |
| EQUITIES AND LIABILITIES | | | | | |
| SHAREHOLDER'S FUNDS | | | | | |
| Equity Share Capital | 21.56 | 21.56 | 21.56 | 21.56 | 19.62 |
| Preference Share Capital | 130.00 | 130.00 | 130.00 | 130.00 | 0.00 |
| Total Share Capital | 151.56 | 151.56 | 151.56 | 151.56 | 19.62 |
| | | | | | |
| Reserves and Surplus | -167.80 | -140.78 | -121.02 | -96.65 | -66.52 |
| Total Reserves and Surplus | -167.80 | -140.78 | -121.02 | -96.65 | -66.52 |
| Money Received Against Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 4.17 |
| Total Shareholders Funds | -16.24 | 10.78 | 30.54 | 54.91 | -42.73 |
| | | | | | |
| NON-CURRENT LIABILITIES | | | | | |
| Long Term Borrowings | 31.25 | 53.50 | 43.25 | 2.93 | 100.55 |
| Other Long Term Liabilities | 50.21 | 51.56 | 51.79 | 53.60 | 52.71 |
| Long Term Provisions | 0.29 | 0.49 | 0.31 | 0.30 | 0.50 |
| Total Non-Current Liabilities | 81.75 | 105.56 | 95.34 | 56.83 | 153.76 |
| | | | | | |
| CURRENT LIABILITIES | | | | | |
| Short Term Borrowings | 50.96 | 9.93 | 9.99 | 9.99 | 0.00 |
| Trade Payables | 18.15 | 18.97 | 15.28 | 37.91 | 20.78 |
| Other Current Liabilities | 34.01 | 32.32 | 23.09 | 29.58 | 26.59 |
| Short Term Provisions | 0.40 | 0.62 | 0.75 | 0.59 | 0.82 |
| Total Current Liabilities | 103.53 | 61.83 | 49.10 | 78.06 | 48.19 |
| | | | | | |
| Total Capital And Liabilities | 169.04 | 178.17 | 174.98 | 189.81 | 159.22 |
| | | | | | |
| ASSETS | | | | | |
| NON-CURRENT ASSETS | | | | | |
| Tangible Assets | 145.23 | 149.30 | 146.47 | 137.69 | 116.26 |
| Intangible Assets | 0.47 | 0.66 | 0.84 | 1.02 | 1.66 |
| Capital Work-In-Progress | 1.24 | 0.16 | 2.24 | 6.53 | 10.09 |
| Intangible Assets Under Development | 1.85 | 1.85 | 1.85 | 1.85 | 1.85 |
| Fixed Assets | 148.79 | 151.96 | 151.40 | 147.09 | 129.86 |
| Other Non-Current Assets | 9.98 | 8.77 | 7.52 | 7.23 | 7.94 |
| Total Non-Current Assets | 158.78 | 160.73 | 158.92 | 154.31 | 137.80 |
| | | | | | |
| | | | | | |
| CURRENT ASSETS | | | | | |
| Inventories | 6.03 | 9.80 | 11.95 | 25.56 | 16.60 |
| Trade Receivables | 0.05 | 1.90 | 0.53 | 0.88 | 0.30 |
| Cash And Cash Equivalents | 0.14 | 0.14 | 0.09 | 0.10 | 0.71 |
| OtherCurrentAssets | 4.04 | 5.61 | 3.50 | 8.95 | 3.81 |
| Total Current Assets | 10.26 | 17.44 | 16.06 | 35.49 | 21.42 |
| | | | | | |
| Total Assets | 169.04 | 178.17 | 174.98 | 189.81 | 159.22 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
| Contingent Liabilities | 24.15 | 4.36 | 5.63 | 5.55 | 5.53 |
